169 related articles for article (PubMed ID: 8534263)
1. Inhibition of microsomal cytochromes P450 in rat liver by the tricyclic antidepressant drug desipramine and its primary oxidized metabolites.
McNeil CM; Murray M
Biochem Pharmacol; 1996 Jan; 51(1):15-20. PubMed ID: 8534263
[TBL] [Abstract][Full Text] [Related]
2. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants.
Murray M; Field SL
Biochem Pharmacol; 1992 May; 43(10):2065-71. PubMed ID: 1599495
[TBL] [Abstract][Full Text] [Related]
3. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline.
Murray M
Mol Pharmacol; 1992 Nov; 42(5):931-8. PubMed ID: 1435757
[TBL] [Abstract][Full Text] [Related]
4. Metabolite-intermediate complexation and inhibition of microsomal CYP3A in rat liver by diltiazem.
Trieu L; Murray M
Xenobiotica; 2000 Feb; 30(2):131-40. PubMed ID: 10718121
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based inhibition of CYP activities in rat liver by fluoxetine and structurally similar alkylamines.
Murray M; Murray K
Xenobiotica; 2003 Oct; 33(10):973-87. PubMed ID: 14555335
[TBL] [Abstract][Full Text] [Related]
6. Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion.
Butler AM; Murray M
Mol Pharmacol; 1993 Jun; 43(6):902-8. PubMed ID: 8316222
[TBL] [Abstract][Full Text] [Related]
7. Sequential metabolism of secondary alkyl amines to metabolic-intermediate complexes: opposing roles for the secondary hydroxylamine and primary amine metabolites of desipramine, (s)-fluoxetine, and N-desmethyldiltiazem.
Hanson KL; VandenBrink BM; Babu KN; Allen KE; Nelson WL; Kunze KL
Drug Metab Dispos; 2010 Jun; 38(6):963-72. PubMed ID: 20200233
[TBL] [Abstract][Full Text] [Related]
8. Enhanced inhibition of microsomal cytochrome P450 3A2 in rat liver during diltiazem biotransformation.
Murray M; Butler AM
J Pharmacol Exp Ther; 1996 Dec; 279(3):1447-52. PubMed ID: 8968370
[TBL] [Abstract][Full Text] [Related]
9. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
10. Effect of antidepressant drugs on cytochrome P450 2C11 (CYP2C11) in rat liver.
Wójcikowski J; Haduch A; Daniel WA
Pharmacol Rep; 2013; 65(5):1247-55. PubMed ID: 24399720
[TBL] [Abstract][Full Text] [Related]
11. Reversible and time-dependent inhibition of the hepatic cytochrome P450 steroidal hydroxylases by the proestrogenic pesticide methoxychlor in rat and human.
Li HC; Mani C; Kupfer D
J Biochem Toxicol; 1993 Dec; 8(4):195-206. PubMed ID: 8114062
[TBL] [Abstract][Full Text] [Related]
12. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate.
Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S
J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177
[TBL] [Abstract][Full Text] [Related]
13. Pretranslational down-regulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor alpha.
Nadin L; Butler AM; Farrell GC; Murray M
Gastroenterology; 1995 Jul; 109(1):198-205. PubMed ID: 7797018
[TBL] [Abstract][Full Text] [Related]
14. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
Chang TK; Chen H; Waxman DJ
Drug Metab Dispos; 1994; 22(5):673-9. PubMed ID: 7835216
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based inactivation of CYP2C11 by diclofenac.
Masubuchi Y; Ose A; Horie T
Drug Metab Dispos; 2001 Sep; 29(9):1190-5. PubMed ID: 11502726
[TBL] [Abstract][Full Text] [Related]
16. Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis.
Chen J; Farrell GC
J Gastroenterol Hepatol; 1996 Sep; 11(9):870-7. PubMed ID: 8889968
[TBL] [Abstract][Full Text] [Related]
17. Impact of tamoxifen on peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11, cytochrome P450 3A2, and steroid 5 alpha-reductase.
Chang TK; Chan MM; Holsmer SL; Bandiera SM; Bellward GD
Biochem Pharmacol; 1996 Feb; 51(3):357-68. PubMed ID: 8573203
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 isozymes catalyzing the hepatic microsomal oxidation of 9-anthraldehyde to 9-anthracene carboxylic acid in adult male rats.
Matsunaga T; Iwawaki Y; Watanabe K; Narimatsu S; Yamamoto I; Imaoka S; Funae Y; Yoshimura H
Biol Pharm Bull; 1993 Sep; 16(9):866-9. PubMed ID: 8268852
[TBL] [Abstract][Full Text] [Related]
19. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac.
Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA
Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798
[TBL] [Abstract][Full Text] [Related]
20. In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats.
Levine M; Law EY; Bandiera SM; Chang TK; Bellward GD
J Pharmacol Exp Ther; 1998 Feb; 284(2):493-9. PubMed ID: 9454789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
